Results 1 to 10 of about 15,163 (213)

Familial essential thrombocythemia

The American Journal of Medicine, 1986
Primary or essential thrombocythemia is rarely observed in childhood, and familial occurrence has been reported only once. In this study, essential thrombocythemia is documented in five members of both sexes from two to 62 years of age in three successive generations.
M E, Eyster, S L, Saletan, E M, Rabellino, A, Karanas, T P, McDonald, L A, Locke, J R, Luderer   +6 more
openaire   +2 more sources

Essential Thrombocythemia in Children

Journal of Pediatric Hematology/Oncology, 1999
The objective of this study was to evaluate the clinical course, laboratory findings, and outcomes of children with essential thrombocythemia (ET).The authors analyzed 36 children, ages 6 weeks to 18 years, by combining descriptions of 2 patients observed at their institution with 34 patients reported in the English medical literature.Fifteen patients (
Y, Dror, A, Zipursky, V S, Blanchette
openaire   +2 more sources

Management of Essential Thrombocythemia

Hematology, 2011
Abstract Essential thrombocythemia (ET) is a Philadelphia chromosome (Ph)–negative myeloproliferative neoplasm (MPN) characterized by thrombocytosis and megakaryocytic hyperplasia of the bone marrow, with presence of the JAK2 V617F mutation in 50%-60% of patients. ET evolves to myelofibrosis in a minority of cases, whereas transformation
openaire   +2 more sources

Pipobroman therapy of essential thrombocythemia

European Journal of Haematology, 1986
We report our results with pipobroman (PB) therapy in patients with essential thrombocythemia (ET). 21 consecutive untreated patients were treated with PB from 1975 to 1984. PB was given at a dose of 1 mg/kg/d until platelet count dropped below 600 × 109/l. In 18 patients (86%) a hematological remission was obtained.
MAZZUCCONI, Maria Gabriella, M. Francesconi, A. Chistolini, E. Falcione, A. Ferrari, M. C. Tirindelli, MANDELLI, Franco   +6 more
openaire   +3 more sources

The pathogenesis of essential thrombocythemia

Current Opinion in Hematology, 2011
The identification of new mutations continues to further our understanding of the molecular pathogenesis of essential thrombocythemia and related disorders, and offers opportunities for improvements in diagnosis, risk stratification and disease classification.Molecular lesions in essential thrombocythemia affect two distinct pathways: cytokine ...
openaire   +2 more sources

ESSENTIAL THROMBOCYTHEMIA

Annals of Internal Medicine, 1958
H G, KUPFER, B J, EBBELS, J N, MILLER, G W, THOMA, S, RUSSI   +4 more
openaire   +2 more sources

Current management strategies for polycythemia vera and essential thrombocythemia

Blood Reviews, 2020
Paola Guglielmelli, Alessandro M Vannucchi   +1 more
exaly  

Essential Thrombocythemia

2018
Susmitha Apuri, Kenneth Zuckerman
  +5 more sources

Essential Thrombocythemia

The Journal for Nurse Practitioners, 2023
Ruth Madden Foreman, Richard Brzustowicz
openaire   +1 more source

Report on essential thrombocythemia

Cancer Genetics and Cytogenetics, 1981
openaire   +2 more sources